利益沖突

【聲明】本共識代表《糖尿病患者血糖波動管理專家共識》編寫組的立場。在缺乏隨機對照試驗或臨床實踐問題特殊說明的情況下，參加討論的專家使用的是他們的判斷和經驗。制訂本共識是為臨床提供指導和參考，而不是對所有個體患者的規(guī)定，不能代替臨床醫(yī)生的判斷。

[1]

. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes[J]. Diabetes Care, 2016, 39( 4): 502- 510. .

[2]

?krhaJ, ?oupalJ, ?krhaJ, et al. Glucose variability, HbA1c and microvascular complications[J]. Rev Endocr Metab Disord, 2016, 17( 1): 103- 110. .

[3]

KohnertKD, AugsteinP, ZanderE, et al. Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents[J]. Diabetes Care, 2009, 32( 6): 1058- 1062. .

[4]

CandidoR. Which patients should be evaluated for blood glucose variability？[J] Diabetes Obes Metab, 2013, 15( Suppl 2): 9- 12. .

[5]

CerielloA, ColagiuriS. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations[J]. Diabet Med, 2008, 25( 10): 1151- 1156. .

[6]

SuG, MiS, TaoH, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2011, 10: 19. .

[7]

SuG, MiSH, TaoH, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction[J]. Diabetes Care, 2013, 36( 4): 1026- 1032. .

[8]

CoutinhoM, GersteinHC, WangY, et al. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years[J]. Diabetes Care, 1999, 22( 2): 233- 240.

[9]

JinSM, KimTH, OhS, et al. Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring[J]. Diabet Med, 2015, 32( 2): 274- 279. .

[10]

HsuCR, ChenYT, SheuWH. Glycemic variability and diabetes retinopathy: a missing link[J]. J Diabetes Complications, 2015, 29( 2): 302- 306. .

[11]

呂麗芳，王椿，劉關鍵，等. 自我血糖監(jiān)測對預測糖調節(jié)異常者與糖尿病患者的日內血糖波動的價值[J]. 四川大學學報(醫(yī)學版), 2011， 42( 1): 95- 100.

[12]

InchiostroS, CandidoR, CavalotF. How can we monitor glycaemic variability in the clinical setting？[J] Diabetes Obes Metab, 2013, 15( Suppl 2): 13- 16. .

[13]

JungHS. Clinical implications of glucose variability: Chronic complications of diabetes[J]. Endocrinol Metab (Seoul), 2015, 30( 2): 167- 174. .

[14]

中華醫(yī)學會糖尿病學分會. 中國血糖監(jiān)測臨床應用指南(2015年版)[J]. 中華糖尿病雜志， 2015， 7( 10): 603- 613. .

[15]

喻明，周健，項坤三，等. 動態(tài)監(jiān)測糖耐量正常者血糖水平的漂移變化[J]. 中華醫(yī)學雜志， 2004，( 21): 1788- 1790. .

[16]

ZhengF, LuW, JiaC, et al. Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation[J]. Endocrine, 2010, 37( 1): 201- 208. .

[17]

WangC, LvL, YangY, et al. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus[J]. Clin Endocrinol (Oxf), 2012, 76( 6): 810- 815. .

[18]

何利平，王椿，鐘莉，等. 成都地區(qū)糖耐量正常者血糖水平變化的特征分析[J]. 四川大學學報(醫(yī)學版), 2009， 40( 4): 704- 707. .

[19]

康怡，陸菊明，孫敬芳，等. 不同糖調節(jié)受損人群的血糖波動特征[J]. 中華醫(yī)學雜志， 2009， 89( 10): 669- 672. .

[20]

TangX, LiS, WangY, et al. Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c[J]. Clin Chim Acta, 2016, 461: 146- 150. .

[21]

XiaJ, XuJ, LiB, et al. Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up[J]. Clin Chim Acta, 2017, 466: 162- 166. .

[22]

周健，賈偉平，喻明，等. 上海地區(qū)中國人餐后血糖狀態(tài)的特征[J]. 中華醫(yī)學雜志， 2006， 86( 14): 970- 975. .

[23]

BonoraE, CalcaterraF, LombardiS, et al. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control[J]. Diabetes Care, 2001, 24( 12): 2023- 2029.

[24]

黃敬澤，王健. 血糖波動對2型糖尿病患者血管內皮損傷的影響[J]. 中國老年學雜志， 2010， 30( 21): 3076- 3078. .

[25]

顧霖，陸宏紅，項容. 血糖波動對2型糖尿病患者尿微量白蛋白排泄率的影響[J]. 牡丹江醫(yī)學院學報， 2014，( 5): 49- 51.

[26]

Guideline for management of postmeal glucose in diabetes[J]. Diabetes Res Clin Pract, 2014, 103( 2): 256- 268. .

[27]

中華醫(yī)學會糖尿病學分會. 中國2型糖尿病防治指南(2013年版)[J]. 中華內分泌代謝雜志， 2014， 30( 10): 893- 942. .

[28]

RavelliD, ZemaM, MellaM, et al. Benzoyl radicals from (hetero)aromatic aldehydes. Decatungstate photocatalyzed synthesis of substituted aromatic ketones[J]. Org Biomol Chem, 2010, 8( 18): 4158- 4164. .

[29]

CandidoR. Which patients should be evaluated for blood glucose variability？[J] Diabetes Obes Metab, 2013, 15( Suppl 2): 9- 12. .

[30]

BaoYQ, ZhouJ, ZhouM, et al. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes[J]. Clin Exp Pharmacol Physiol, 2010, 37( 5-6): 564- 568. .

[31]

李曉靜，高政南，程麗靜，等. 采用CGMS評價阿卡波糖對胰島素治療血糖波動的影響[J]. 中華內分泌代謝雜志， 2012， 28( 2): 140- 143. .

[32]

CopelandKC, SilversteinJ, MooreKR, et al. Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents[J]. Pediatrics, 2013, 131( 2): 364- 382. .

[33]

陳莉明. 糖尿病特殊人群的血糖監(jiān)測[J]. 中華糖尿病雜志， 2016， 8( 12): 709- 712. .

[34]

方福生，成曉玲，李志冰，等. 老年2型糖尿病患者血糖波動性別差異的病例對照研究[J]. 中國藥物應用與監(jiān)測， 2013，( 4): 193- 196. .

[35]

方福生，李志冰，成曉玲，等. 老年2型糖尿病患者血糖波動的影響因素[J]. 中華醫(yī)學雜志， 2013， 93( 40): 3202- 3206. .

[36]

中國老年學學會老年醫(yī)學會老年內分泌代謝專業(yè)委員會，老年糖尿病診療措施專家共識編寫組. 老年糖尿病診療措施專家共識(2013年版)[J]. 中華內科雜志， 2014， 53( 3): 243- 251. .

[37]

International Diabetes Federation. Global Guideline for Managing Older People with Type 2 Diabetes[EB/OL]. https://www.idf.org/our-activities/advocacy-awareness/resources-and-tools/78:global-guideline-for-managing-older-people-with-type-2-diabetes.html, 2013.

[38]

中華醫(yī)學會婦產科學分會產科學組，中華醫(yī)學會圍產醫(yī)學分會妊娠合并糖尿病協(xié)作組. 妊娠合并糖尿病診治指南(2014)[J]. 中華婦產科雜志， 2014， 49( 8): 561- 569. .

[39]

中國醫(yī)師協(xié)會內分泌代謝科醫(yī)師分會. 2型糖尿病合并慢性腎臟病口服降糖藥用藥原則中國專家共識(2015年更新版)[J]. 中華內分泌代謝雜志， 2016， 32( 6): 455- 460. .

[40]

高穎，楊光燃，周迎生，等. 心血管疾病合并糖尿病口服降糖藥物應用專家共識[J]. 中華內科雜志， 2014， 53( 10): 833- 838. .

[41]

RydénL, GrantPJ, AnkerSD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)[J]. Eur Heart J, 2013, 34( 39): 3035- 3087. .

相關知識

5 問 5 答解讀《中國 2 型糖尿病患者餐后高血糖管理專家共識》
危重癥患者血糖管理【共識】
糖尿病患者人群健康管理血糖常識
AGI 降糖專題：血糖波動管理——從餐后血糖控制開始
圍術期血糖管理專家共識（2021版）
緩解2型糖尿病中國專家共識
首次明確并列靶點：《糖尿病患者血脂管理中國專家共識（2024 版）》彭道泉教授解讀
中國2型糖尿病體重管理共識發(fā)布：應減脂增肌，避免體重波動！
聯(lián)合國糖尿病日：體重管理助力糖尿病患者提升幸福感
新共識！糖尿病患者如何進行體重管理？4大要點總結

網址: 糖尿病患者血糖波動管理專家共識 http://www.u1s5d6.cn/newsview638307.html